Chris Bosh is incapable of being a basketball player.
ADSB-FUB-187 is an indazole-based synthetic cannabinoid .. indazole. indazole. synthetic cannabinoid. synthetic cannabinoid. It is a potent agonist of the CB1 receptor with a binding affinity of Ki = 0.09 nM and an EC50 of 1.09 nM .. agonist. agonist. binding affinity. binding affinity. It was originally developed by Pfizer in 2009 , being example 187 from patent WO 2009 / 106982 .. Pfizer. Pfizer. While it is the most tightly binding compound from this patent in terms of Ki , it is not the most potent compound at producing a CB1 mediated pharmacological effect , with at least 17 other compounds from the patent having lower EC50 values .